Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Humm

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Development of <sup>18</sup>F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and PerformanceRick Wray, Audrey Mauguen, Laure Michaud, et al.
Computational and Structural Biotechnology Journal|November 30, 2023
Preoperative <sup>18</sup>F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinomaWookjin Choi, Chia-Ju Liu, Sadegh Riyahi Alam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2003
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanningPat Zanzonico, Joseph O'Donoghue, J Donald Chapman, et al.
Health Physics|February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancerLawrence T Dauer, Matthew J Williamson, John Humm, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
Science Translational Medicine|October 31, 2014
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probeEvan Phillips, Oula Penate-Medina, Pat B Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2018
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine ModelsEla Markovsky, Sadna Budhu, Robert M Samstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical TherapyChaitanya Divgi, Jorge A Carrasquillo, Ruby Meredith, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
Development of <sup>18</sup>F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and PerformanceRick Wray, Audrey Mauguen, Laure Michaud, et al.
Computational and Structural Biotechnology Journal|November 30, 2023
Preoperative <sup>18</sup>F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinomaWookjin Choi, Chia-Ju Liu, Sadegh Riyahi Alam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2003
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanningPat Zanzonico, Joseph O'Donoghue, J Donald Chapman, et al.
Health Physics|February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancerLawrence T Dauer, Matthew J Williamson, John Humm, et al.
The Lancet. Oncology|March 31, 2007
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trialChaitanya R Divgi, Neeta Pandit-Taskar, Achim A Jungbluth, et al.
Science Translational Medicine|October 31, 2014
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probeEvan Phillips, Oula Penate-Medina, Pat B Zanzonico, et al.
International Journal of Radiation Oncology, Biology, Physics|October 21, 2018
An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine ModelsEla Markovsky, Sadna Budhu, Robert M Samstein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2016
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal CarcinomaNancy Lee, Heiko Schoder, Brad Beattie, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical TherapyChaitanya Divgi, Jorge A Carrasquillo, Ruby Meredith, et al.
Pageof 8